ASX-listed Cann Global is stepping up its marketing of Australia’s first hard-pill medicinal cannabis product insisting the formulation will open up an entirely new market for the medicine.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The arrival and distribution of the oral dose CBD products — that have patent protection in Australia — will remove significant barriers for doctors who are uncomfortable prescribing oil and flower, Cann Global chief executive Sholom Feldman said.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...